France· FR:62276016
INLURIYO 200 mg, comprimés pelliculés
A medicinal product containing tosilate d'imlunestrant, registered in France by ELI LILLY NEDERLAND BV (PAY-BAS).
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- TOSILATE D'IMLUNESTRANT
- Manufacturer
- ELI LILLY NEDERLAND BV (PAY-BAS)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip133400930339138plaquette(s) thermoformée(s) polychlortrifluoroéthylène PVC-Aluminium de 56 comprimé(s)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tosilate d'imlunestrant in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaINLURIYOEli Lilly Nederland B.V., Utrecht
- SwitzerlandInluriyo 200 mg, comprimés pelliculésEli Lilly (Suisse) SA
- United StatesInluriyoEli Lilly and Company
- BelgiumInluriyo 200 mgEli Lilly Nederland
- NetherlandsInluriyo 200 mg filmomhulde tablettenEli Lilly Nederland B.V.
- PolandInluriyoEli Lilly Nederland B.V.
- SwedenInluriyo 200 mg Filmdragerad tablettEli Lilly Nederland B.V.
- IcelandInluriyoEli Lilly Nederland B.V.*
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Inluriyo
- Liechtenstein · Inluriyo
- Norway · Inluriyo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/35b4e718-3b37-45bd-ba95-fa3c3f2f97ad GET /v1/drugs/35b4e718-3b37-45bd-ba95-fa3c3f2f97ad?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "62276016",
"date_amm": "2026-01-09",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/25/2003",
"substance": "TOSILATE D'IMLUNESTRANT",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about tosilate d'imlunestrant.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.